ArticleJournal of animal science2025
Effects of omega-3 polyunsaturated fatty acid supplementation to first-calf beef heifers during late gestation on offspring physiology and performance.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Eicosapentaenoic Acid Improves Porcine Oocyte Cytoplasmic Maturation and Developmental Competence via Antioxidant and Mitochondrial Regulatory Mechanisms.Antioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Forty-four pregnant Angus first-calf heifers (initial body weight [BW] = 490 ± 8 kg, body condition score [BCS] = 5.4 ± 0.06) were selected and assigned to the experiment at the end of their second trimester of gestation. From day 0 until calving, first-calf heifers were gathered and individually fed 3 times a week with dry distillers' grain (DDG; 3.5 kg/heifer per feeding; as-fed basis) + treatments. Treatments were 1) 234 g/heifer per feeding of Ca salts of PUFA based on eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids (OMG, Strata; Virtus Nutrition LLC, Corcoran, CA; n = 22), or 2) 234 g/heifer per feeding of Ca salts of saturated and monosaturated fatty acids based on palmitic and oleic acids (CON; EnerGII, Virtus Nutrition; n = 22). From day -11 (d of gestation 192 ± 5.1) to calving, heifers were allocated to rangeland pasture. First-calf heifer BW and BCS were recorded (days -10 and -9), and blood was collected on day -10, and upon calving. Calves were weaned on day 260, and preconditioned from days 260 to 302, and feedlot was received from days 303 to 350. No differences were detected (P ≥ 0.33) for heifer BW or BCS changes at calving. A tendency for greater concentration of colostrum IgG (P = 0.08) was observed in heifers supplemented with OMG vs. CON cohorts. There were no differences (P ≥ 0.31) among treatments at calving for calving rate, birth BW, heart girth, and % of male calves born. Calves from OMG heifers had greater (P = 0.04) plasma IgG concentration compared to CON calves. No differences were observed (P ≥ 0.11) for weaning rate and age, birth to weaning average daily gain (ADG), weaning weight, liver enzymes, and serum antibodies against respiratory viruses. During the preconditioning, OMG calves had greater (P ≤ 0.05) final BW and ADG compared with calves born to CON heifers. These differences in performance remained (P ≤ 0.05) throughout the receiving phase. A treatment × day interaction was detected (P = 0.05) for plasma cortisol concentration, which was greater (P < 0.01) for calves born to OMG first-calf heifers on days 260 and 263 and lower (P < 0.01) on day 306 compared to CON cohorts. Supplementing omega-3 fatty acids to late-gestating first-calf beef heifers enhances IgG concentrations in both heifers and their offspring. While offspring growth from birth to weaning remained unaffected, OMG calves demonstrated increased weight during the preconditioning and receiving phases, suggesting potential long-term growth benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.